UTAH MEDICAL PRODUCTS INC(UTMD)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

UTAH MEDICAL PRODUCTS INC (UTMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores UTMD at 48.8/100 on a 32-signal composite quality model, placing it at rank #1,701 of 2,962 stocks — the bottom half of the AI-ranked universe. UTMD scores in the top quartile across free cash flow (85.4), profitability (85.0), balance sheet strength (82.2). Areas of concern include revenue scale (6.5) and revenue growth (6.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), UTAH MEDICAL PRODUCTS INC reports quarterly revenue of $8.5M, net income of $2.7M, an operating margin of 31.1%. Top institutional holders of UTMD by reported 13-F value include BRANDES INVESTMENT PARTNERS, BlackRock, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. UTMD trades on the Nasdaq exchange and files with the SEC under CIK 706698. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UTMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UTAH MEDICAL PRODUCTS INC directly from SEC EDGAR.